Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bergrem

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Diabetes, Nutrition & Metabolism|June 13, 2002
Quality of care for persons with diabetic nephropathy: timeliness of first referral to nephrologistH Bergrem
Kidney International|June 1, 1983
Pharmacokinetics and protein binding of prednisolone in patients with nephrotic syndrome and patients undergoing hemodialysisH Bergrem
Acta Medica Scandinavica|January 1, 1983
The influence of uremia on pharmacokinetics and protein binding of prednisoloneH Bergrem
Acta Ophthalmologica Scandinavica|October 1, 1996
Diabetic eye complications in a medium sized municipality in southwest NorwayR Hapnes, H Bergrem
Scandinavian Journal of Gastroenterology|May 1, 1983
Bioavailability of prednisolone in patients with intestinal malabsorption: the importance of measuring serum protein-bindingH Bergrem, I Opedal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 5, 2000
[Use of information technology in quality development of diabetic care]S Skeie, H Bergrem
Lancet (London, England)|November 25, 1978
Dialysis death and increased free fatty acidsH Bergrem, T Leivestad
Advances in Renal Replacement Therapy|February 15, 2001
Diabetic nephropathy and end-stage renal failure: the Norwegian storyH Bergrem, T Leivestad
Acta Medica Scandinavica|January 1, 1983
Altered prednisolone pharmacokinetics in patients treated with rifampicinH Bergrem, O K Refvem
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Changes in prednisolone pharmacokinetics and protein binding during treatment with rifampicinH Bergrem, O K Refvem
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Diabetes, Nutrition & Metabolism|June 13, 2002
Quality of care for persons with diabetic nephropathy: timeliness of first referral to nephrologistH Bergrem
Kidney International|June 1, 1983
Pharmacokinetics and protein binding of prednisolone in patients with nephrotic syndrome and patients undergoing hemodialysisH Bergrem
Acta Medica Scandinavica|January 1, 1983
The influence of uremia on pharmacokinetics and protein binding of prednisoloneH Bergrem
Acta Ophthalmologica Scandinavica|October 1, 1996
Diabetic eye complications in a medium sized municipality in southwest NorwayR Hapnes, H Bergrem
Scandinavian Journal of Gastroenterology|May 1, 1983
Bioavailability of prednisolone in patients with intestinal malabsorption: the importance of measuring serum protein-bindingH Bergrem, I Opedal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 5, 2000
[Use of information technology in quality development of diabetic care]S Skeie, H Bergrem
Lancet (London, England)|November 25, 1978
Dialysis death and increased free fatty acidsH Bergrem, T Leivestad
Advances in Renal Replacement Therapy|February 15, 2001
Diabetic nephropathy and end-stage renal failure: the Norwegian storyH Bergrem, T Leivestad
Acta Medica Scandinavica|January 1, 1983
Altered prednisolone pharmacokinetics in patients treated with rifampicinH Bergrem, O K Refvem
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Changes in prednisolone pharmacokinetics and protein binding during treatment with rifampicinH Bergrem, O K Refvem
Pageof 3